Home LiteratureArticle Details
PMID: 14715846 Published · ppublish English Journal Article

Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.

The Journal of clinical endocrinology and metabolism ·Vol. 89 ·No. 1 ·2004-01-00 ·Pages 174-80

De Marinis L, Bianchi A, Mancini A, Gentilella R, Perrelli M, Giampietro A, Porcelli T, Tilaro L, Fusco A, Valle D, Tacchino RM

Abstract

Obesity is characterized by increased leptin levels and insulin resistance, whereas blunted GH secretion is paired with normal, low, or high plasma IGF-I levels. To investigate body composition in human obesity and the interactions among the GH-IGF-I axis, leptin, and insulin resistance [measured with the homeostasis model assessment (HOMA) score], we studied 15 obese females, aged 23-54 yr (mean age, 42.7 +/- 2.6), with a body mass index (BMI) of 44.02 +/- 1.45 kg/m(2), who underwent treatment by biliopancreatic diversion (BPD), before and after surgery (16-24 months; BMI, 28.29 +/- 0.89 kg/m(2)). Our controls were 15 normal females, aged 28-54 yr (mean age, 40.8 +/- 2.3 yr), with a BMI of 27.52 +/- 0.53 kg/m(2). Insulin and leptin levels and HOMA scores were higher pre-BPD than in the controls. The GH response to GHRH was blunted, with a GH peak and GH area under the curve (AUC) significantly lower than those in controls. IGF-I and IGF-binding protein-3 (IGFBP-3) were also lower than control values. After surgery, BMI, fat mass, lean body mass, HOMA, insulin, and leptin significantly decreased. Furthermore, the GH response to GHRH severely increased; IGF-I and IGFBP-3 levels did not significantly vary. Considering all subjects, correlation analysis showed a strong positive correlation between insulin and leptin, and a negative correlation between insulin and GH peak and between insulin and GH AUC. Regression analysis performed grouping pre- and post-BPD indicated that leptin and GH peak or AUC could best be predicted from insulin levels. The surgical treatment of severe obesity after stabilization of body weight decreases BMI and fat mass while preserving normal lean body mass as well as positively influencing insulin sensitivity and thus aiding the normalization of leptin levels. The insulin reduction may be mainly involved in the increase in the GH response to GHRH through various possible central and peripheral mechanisms while decreasing the peripheral sensitivity to GH itself, as shown by the stable nature of the IGF-I and IGFBP-3 values. Our findings suggest that the changes in insulin levels are the starting point for changes in both leptin levels and the somatotrope axis after BPD.

MeSH Terms
Adipose Tissue Adult Biliopancreatic Diversion Body Composition Body Mass Index Female Growth Hormone-Releasing Hormone Homeostasis Human Growth Hormone/metabolism Humans Insulin/blood Insulin Resistance Insulin-Like Growth Factor Binding Protein 3/blood Insulin-Like Growth Factor I/analysis Leptin/blood Middle Aged Obesity, Morbid/physiopathology,surgery Regression Analysis
Chemicals
Insulin Insulin-Like Growth Factor Binding Protein 3 Leptin Human Growth Hormone Insulin-Like Growth Factor I Growth Hormone-Releasing Hormone
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
De Marinis L
Institute of Endocrinology, Catholic University School of Medicine, 00168 Rome, Italy. [email protected]
Bianchi A
Mancini A
Gentilella R
Perrelli M
Giampietro A
Porcelli T
Tilaro L
Fusco A
Valle D
Tacchino R M
Article Info
Journal
The Journal of clinical endocrinology and metabolism
Abbr.
J Clin Endocrinol Metab
ISSN
0021-972X
Published
2004-01-00
Pages
174-80
Language
English
Region
United States
NLM ID
0375362
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]